Cytokinetics Inc (CYTK): Revenue
$88.04M
Year ended 2025-12-31
$67.67M
Trailing 12 months to 2026-06-30
-2.4%
3-year compound annual growth
+9.5%
5-year compound annual growth
+11.9%
10-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $88.04M | +376.6% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $18.47M | +145.3% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $7.53M | -92.0% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $94.59M | +34.3% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $70.43M | +26.2% | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | $55.83M | +107.8% | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | $26.87M | -14.7% | 2022-02-25, From 2019-01-01 |
| 2018-12-31 | $31.50M | +135.6% | 2021-02-26, From 2018-01-01 |
| 2017-12-31 | $13.37M | -87.4% | 2019-03-07, From 2017-01-01 |
| 2016-12-31 | $106.41M | +271.3% | 2018-03-05, From 2016-01-01 |
| 2015-12-31 | $28.66M | -38.9% | 2018-03-05, From 2015-01-01 |
| 2014-12-31 | $46.94M | +53.2% | 2017-03-06, From 2014-01-01 |
| 2013-12-31 | $30.65M | +305.5% | 2016-03-03, From 2013-01-01 |
| 2012-12-31 | $7.56M | +89.0% | 2015-03-06, From 2012-01-01 |
| 2011-12-31 | $4.00M | +55.2% | 2014-03-07, From 2011-01-01 |
| 2010-12-31 | $2.58M | -96.8% | 2013-03-15, From 2010-01-01 |
| 2009-12-31 | $81.54M | n/a | 2012-03-13, From 2009-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Cytokinetics Inc (CYTK) | 2025-12-31 | $88.04M | +376.6% |
| Standard Biotools Inc. (LAB) | 2025-12-31 | $85.33M | -6.2% |
| ARS Pharmaceuticals, Inc. (SPRY) | 2025-12-31 | $84.28M | -5.5% |
| Nurix Therapeutics, Inc. (NRIX) | 2025-11-30 | $83.98M | +54.0% |
| Arcturus Therapeutics Holdings Inc. (ARCT) | 2025-12-31 | $82.03M | -46.1% |
| Siga Technologies Inc (SIGA) | 2025-12-31 | $94.57M | -31.8% |
| ADC Therapeutics SA (ADCT) | 2025-12-31 | $81.36M | +14.9% |
| Eton Pharmaceuticals, Inc. (ETON) | 2025-12-31 | $79.95M | +104.9% |
| CytomX Therapeutics, Inc. (CTMX) | 2025-12-31 | $76.20M | -44.8% |
Compare CYTK, LAB, SPRY, NRIX side by side · Screen every company in Pharmaceutical Preparations ↗